Q3 2025 Equity Capital Markets Review
Equity capital markets sustained strong momentum through the third quarter of 2025, with major U.S. indices reaching new record highs...
ICR Review: The Semi-Annual Reporting Debate
The question of whether U.S. public companies should report earnings every three months or every six months has re-emerged after...
Using AI to Help you Take Control of Your Health
In today’s medical system, getting a proper diagnosis and course of treatment can take ages, with potentially disastrous consequences for...
Convertible Market Strength and Healthcare Momentum: Recent Deals with Celcuity, Ligand, and Oscar Health
Despite macroeconomic and geopolitical uncertainty, the convertible bond market is experiencing a goldilocks moment in 2025. Equity valuations have risen...
Earnings Prep Season: Our Approach to Navigating Results
Earnings preparation is one of the most critical recurring activities for any public company. Across our global client base, management...
DC Insider—News from Washington: Government Shutdown Begins
In the October 2025 edition of The ICR D.C. Insider, the Federal Government shutdown begins, the Supreme Court to...
Cancer Communications in a Volatile Cycle: Think Like Policy, Act for Patients
Year over year, federal research support has fallen sharply—analyses estimate roughly $2.7 billion less in NIH research funding in the...
Children’s Clothing Brand Stands the Test of Time | Aimée Lapic
Since the 1980s, beloved children’s clothing brand Hanna Andersson has been delivering quality and durability to happy customers. Now, Aimée...
Navigating the FDA’s New Real-Time CRL Publication Policy: Strategic Communications and Risk Management for Life Sciences Companies
The FDA announced a significant policy shift that will fundamentally change how drug approval information becomes public. Effective immediately, the...
